Medicolegal Considerations in the Treatment of Psychosis With Second-Generation Antipsychotics

摘要

Are the metabolic side effects of the atypical antipsychotics fueling the next round of malpractice suits being filed against psychiatrists? Guidelines are being created, but how can clinicians protect themselves and their patients, while continuing to give their patients the best care available?